 Treatment acute myeloid leukaemia renal allograft recipient implications cyclosporin immunosuppressive treatment clinical effects cyclosporin cytotoxic treatment year old man acute myeloid leukaemia renal transplant months acute myeloid leukaemia FAB cyclosporin mg/kg plasma cyclosporin concentration ng/ml Cyclosporin induction chemotherapy daunorubicin cytarabine DAT fever oropharyngeal candidiasis unresponsive anti-bacterial drugs amphotericin Bone marrow examination days chemotherapy complete haematological remission consolidation treatment DAT serious complications fatal septicaemia second consolidation mitozantrone cytarabine Inhibition P-glycoprotein activity cyclosporin toxicity aggressive chemotherapeutic regimens benefit approach clinical evaluation justified